Amoy Diagnostics Co., Ltd.
Symbol: 300685.SZ
SHZ
20.6
CNYDzisiejsza cena rynkowa
34.8241
Wskaźnik P/E
0.0000
Wskaźnik PEG
8.13B
Kapitalizacja MRK
- 0.01%
Rentowność DIV
Amoy Diagnostics Co., Ltd. (300685-SZ) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 0 | 754 | 718.7 | ||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 259.3 | 315.9 | ||||||||||||
balance-sheet.row.net-receivables | 0 | 0 | 478.8 | 437.6 | ||||||||||||
balance-sheet.row.inventory | 0 | 0 | 32.8 | 32.3 | ||||||||||||
balance-sheet.row.other-current-assets | 0 | 0 | 19.5 | 7.4 | ||||||||||||
balance-sheet.row.total-current-assets | 0 | 0 | 1285.1 | 1196 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 0 | 208.3 | 209.5 | ||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 47.2 | 19.1 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 47.2 | 19.1 | ||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | -200.7 | -248.2 | ||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 6.5 | 20.5 | ||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 304.5 | 323.1 | ||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 0 | 365.8 | 323.9 | ||||||||||||
balance-sheet.row.other-assets | 0 | 1946.5 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 0 | 1946.5 | 1650.9 | 1519.9 | ||||||||||||
balance-sheet.row.account-payables | 0 | 0 | 21.3 | 24 | ||||||||||||
balance-sheet.row.short-term-debt | 0 | 0 | 5.3 | 3.1 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 8.8 | 17.1 | ||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 48.3 | 3 | ||||||||||||
Deferred Revenue Non Current | 0 | 0 | 10.3 | 11.2 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 0 | 0 | 0.6 | 0.1 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 0 | 59.2 | 15 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 1.7 | 3 | ||||||||||||
balance-sheet.row.total-liab | 0 | 0 | 151.2 | 150.3 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0 | 398.6 | 398.2 | 221.7 | ||||||||||||
balance-sheet.row.retained-earnings | 0 | 0 | 827.7 | 637.2 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 3.5 | 91.6 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 1302.5 | 270.4 | 414.1 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1701.1 | 1499.7 | 1364.6 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 0 | 1650.9 | 1519.9 | ||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 5.1 | ||||||||||||
balance-sheet.row.total-equity | 0 | 1701.1 | 1499.7 | 1369.6 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||
Total Investments | 0 | 0 | 58.6 | 67.6 | ||||||||||||
balance-sheet.row.total-debt | 0 | 0 | 53.6 | 6.1 | ||||||||||||
balance-sheet.row.net-debt | 0 | 0 | -441 | -396.8 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 256.3 | 264.3 | 239 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 52.3 | 38.9 | ||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 13.7 | -1.1 | ||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | -13.7 | 1.1 | ||||||||||||
cash-flows.row.change-in-working-capital | 0 | 0 | -58.9 | -125.1 | ||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 25.9 | -132.3 | ||||||||||||
cash-flows.row.inventory | 0 | 0 | -0.6 | -10.8 | ||||||||||||
cash-flows.row.account-payables | 0 | 0 | -98 | 19.2 | ||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 13.7 | -1.1 | ||||||||||||
cash-flows.row.other-non-cash-items | 0 | -256.3 | -108.6 | 15.4 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -78.3 | -74.5 | ||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 51.9 | 8.9 | ||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -363.6 | -772.1 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 350.2 | 600.7 | ||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | -0.5 | -5.6 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 0 | -40.2 | -242.7 | ||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -1.1 | 0 | ||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 100.7 | 0 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -100.7 | -4.4 | ||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -51.5 | -55.4 | ||||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | -68 | 13.5 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 0 | -120.6 | -46.3 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 24.6 | -10 | ||||||||||||
cash-flows.row.net-change-in-cash | 0 | 0 | 12.9 | -130.8 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 244 | 243.6 | 230.7 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 244 | 230.7 | 361.6 | ||||||||||||
cash-flows.row.operating-cash-flow | 0 | 0 | 149 | 168.2 | ||||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | -78.3 | -74.5 | ||||||||||||
cash-flows.row.free-cash-flow | 0 | 0 | 70.8 | 93.6 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1043.6 | 842.2 | 917 | ||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 0 | 147.8 | 143.3 | ||||||||||||
income-statement-row.row.gross-profit | 0 | 1043.6 | 694.4 | 773.8 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 0 | -748.4 | -1.6 | -1.3 | ||||||||||||
income-statement-row.row.operating-expenses | 0 | 748.4 | 524.3 | 508.9 | ||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 748.4 | 672.1 | 652.2 | ||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 6.1 | 3.1 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 1 | 0.4 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -6.4 | -1.6 | -1.3 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -748.4 | -1.6 | -1.3 | ||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -6.4 | -1.6 | -1.3 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 1 | 0.4 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | -32.5 | 52.3 | 38.9 | ||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | 0 | 295.1 | 287.7 | 253.2 | ||||||||||||
income-statement-row.row.income-before-tax | 0 | 288.7 | 286.1 | 252 | ||||||||||||
income-statement-row.row.income-tax-expense | 0 | 32.5 | 21.8 | 13 | ||||||||||||
income-statement-row.row.net-income | 0 | 256.3 | 263.7 | 239.6 |
Często zadawane pytania
Ile wynosi Amoy Diagnostics Co., Ltd. (300685.SZ) aktywów ogółem?
Amoy Diagnostics Co., Ltd. (300685.SZ) całkowite aktywa to 1946538300.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to N/A.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.889.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 0.444.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.246.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.283.
Co to jest Amoy Diagnostics Co., Ltd. (300685.SZ) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 256255700.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 0.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 748437800.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 0.000.